Detalhe da pesquisa
1.
A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study.
Int J Clin Oncol
; 27(9): 1467-1476, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767079
2.
Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma.
Cancer Sci
; 111(4): 1392-1406, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31975570
3.
Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.
Int J Urol
; 26(4): 506-520, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30818424
4.
Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.
Cancer Sci
; 109(9): 2919-2936, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29968393
5.
Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
Cancer Sci
; 109(4): 1239-1253, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29417701
6.
Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.
J Hum Genet
; 63(2): 195-205, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29196733
7.
Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
J Hum Genet
; 63(5): 657-668, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29540855
8.
Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Int J Urol
; 25(11): 953-965, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153702
9.
Vasovasostomy and vasoepididymostomy: Review of the procedures, outcomes, and predictors of patency and pregnancy over the last decade.
Reprod Med Biol
; 17(4): 343-355, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30377390
10.
Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.
Cancer Sci
; 108(8): 1681-1692, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28612520
11.
Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
Cancer Sci
; 108(10): 2088-2101, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28746769
12.
Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.
Br J Cancer
; 117(3): 409-420, 2017 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28641312
13.
Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.
J Hum Genet
; 62(1): 123-132, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27278788
14.
Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
Int J Mol Sci
; 18(9)2017 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28902136
15.
Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
Cancer Sci
; 107(1): 84-94, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26509963
16.
Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.
Br J Cancer
; 114(10): 1135-44, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27070713
17.
Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.
J Hum Genet
; 61(2): 109-18, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26490187
18.
Testicular function among testicular cancer survivors treated with cisplatin-based chemotherapy.
Reprod Med Biol
; 15(3): 175-181, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29259434
19.
MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
Br J Cancer
; 113(7): 1055-65, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26325107
20.
Management of men with a suspicion of prostate cancer after negative initial prostate biopsy results.
Urol Int
; 92(3): 258-63, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24642795